Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle Chemotherapy

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

405

Participants

Timeline

Start Date

July 31, 1999

Primary Completion Date

March 31, 2002

Study Completion Date

June 30, 2002

Conditions

AnemiaSolid Tumors

Interventions

DRUG

Placebo

DRUG

Novel Erythropoiesis Stimulating Protein (NESP) (darbepoetin alfa)